Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by hmmmmmmmmon Mar 24, 2023 2:27pm
224 Views
Post# 35359154

The reasons for a 87M dollar Market Cap?

The reasons for a 87M dollar Market Cap?Spectral currently has an 87M cap.  a weak .315 cents a share

It's becoming clear that there are two main reasons for this.

Reason 1: PMX's value as a breakthrough device. I agree with MM and others who argue that today's price is a ridiculous reflection of PMXs value once approved. It is why I invested here years ago- and heavily.

Reason 2: Management. Their inability to get any traction with a 150 person trial is the reason for today's crippled share price, while it also steals from future 
value through repeated, heavy dilution.

It's seems quite clear that we are at 87M instead of 187M or 287M because Seto aand Kellum have not delivered a sliver of what they promised.

With each passing month Spectral's enrollment track record becomes more undeniable. Their excuses become more unbelievable.

How will they raise with those numbers?

And how long will we continue to pay Seto and Kellum to hold the share price down?

I remeber when Seto used our money to hire a CRO to run the DIMI trial.


<< Previous
Bullboard Posts
Next >>